- Cash
Volume Analysis
SPOT Pivot Levels
| Type | Classic | Fibonacci |
|---|---|---|
| R1 | 54.06 | 53.3 |
| R2 | 55.71 | 54.22 |
| R3 | 57.96 | 55.71 |
| PP | 51.81 | 51.81 |
| S1 | 54.06 | 53.3 |
| S2 | 47.91 | 49.4 |
| S3 | 46.26 | 47.91 |
Ratios
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| ROCE | 7.28 | - | 6.72 | - | 11.33 |
| ROE | 5.32 | - | 4.78 | - | 8.6 |
| EPS | 0.37 | 0.43 | 0.26 | 0.15 | 0.2 |
Peer Comparison
| Scrip Name | Price | Daily change | M Cap | PE Ratio | 1 Year Return |
|---|
Corporate Action
- Announcements
- Board Meetings
- Dividends
- Bonus
- Splits
- Rights
- AGM/EGM
- Credit Rating
About Morepen Laboratories Ltd
Morepen Laboratories Limited is an India-based pharmaceutical company. Its products include Loratadine, Montelukast Sodium, Atorvastatin Calcium and Sultamicillin. The company markets formulation products in various therapeutic categories, such as antibiotics, gastrointestinal, respiratory, analgesic, antiallergic and neuropsychiatry with brands, such as Saltum, Saltumax, Cefpopen, Cefpen-S, Dom-D...
ISIN :INE083A01026
Registered Office
Morepen Village,Nalagarh Road Near Baddi
Contact number
+ 91-01795-276201-03
Registrars
Mas Services Limited
T-34 2nd Floor Okhla Industrial Are Phase II New Delhi - 110020
T-34 2nd Floor Okhla Industrial Are Phase II New Delhi - 110020
Contact number
+ 91-011-26387281/83
Management
Sushil Suri (Chairman)
Open IPO’s
FAQs
The share price of Morepen Laboratories Ltd on the BSE is - as on -